Healthcare Services

Convalescent plasma therapy market forecast with growth insights

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Convalescent Plasma Therapy Market Progress Between 2026 And 2030?

The convalescent plasma therapy market has experienced rapid growth in recent years. Its valuation is projected to rise from $0.06 billion in 2025 to $0.06 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.6%. Historically, this expansion has been attributed to urgent pandemic treatment demand, the lack of targeted therapeutics, the availability of recovered donors, emergency use authorizations, and hospital-based plasma transfusion.

The convalescent plasma therapy market is projected for substantial expansion in the coming years. Its valuation is set to reach $0.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. This growth throughout the forecast period stems from factors such as enhanced preparedness for future outbreaks, progress in antibody testing methods, improvements in plasma storage technologies, the broadening of transfusion services, and intensified research into immune therapies. Key developments anticipated during this period encompass an increasing application in treating emerging infectious diseases, a heightened emphasis on high-titer antibody plasma, the expansion of infrastructure for plasma collection, more refined donor screening and selection processes, and its incorporation into hospital critical care settings.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

What Major Factors Are Driving The Convalescent Plasma Therapy Market Forward?

The growing incidence of infectious diseases is expected to drive the expansion of the Convalescent Plasma Therapy market. These illnesses, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, are transmissible among individuals or through contaminated environments. The increasing prevalence of infectious diseases is linked to heightened urbanization and global travel, which facilitate closer human contact and quicker pathogen spread. Convalescent plasma therapy helps combat these diseases by utilizing plasma from recovered patients; this plasma contains antibodies that can neutralize pathogens and provide passive immunity to those currently infected, thereby strengthening the body’s defense against the disease. For instance, in October 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from 7.5 million in 2022, representing the highest number recorded since global TB surveillance began. Consequently, the rising prevalence of infectious diseases is a key factor propelling the growth of the Convalescent Plasma Therapy market.

How Is The Convalescent Plasma Therapy Market Segmented Across Different Segment Categories?

The convalescent plasma therapy market covered in this report is segmented –

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma

Which Trends Are Impacting The Progress Of The Convalescent Plasma Therapy Market?

Leading companies in the convalescent plasma therapy market are concentrating on developing innovative solutions, such as hyperimmune globulin therapies, to boost treatment effectiveness and tackle issues associated with standard plasma treatments. Hyperimmune Globulin Therapies involve treatments that utilize plasma with a high concentration of specific antibodies, obtained from individuals who have recovered from an infection, to offer targeted and potent immune support for patients. For instance, in October 2023, Kamada Ltd., an Israel-based biopharmaceutical company, announced significant progress regarding its product CYTOGAM (Cytomegalovirus Immune Globulin Intravenous [Human]), which is now commercially available in the U.S. following FDA approval for its manufacturing facility in Israel. At IDWeek 2023, new clinical data showcased a five-year survival advantage for high-risk CMV mismatch lung transplant patients receiving CYTOGAM. Additionally, Kamada has established its first Scientific Advisory Board to enhance U.S. clinical programs for the product.

Which Organizations Play A Role In The Convalescent Plasma Therapy Market Landscape?

Major companies operating in the convalescent plasma therapy market are Bio Farma, Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank, Kedrion Biopharma Inc.

Get The Full Convalescent Plasma Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Which Region Is The Largest In The Convalescent Plasma Therapy Market?

North America was the largest region in the convalescent plasma therapy market in 2025. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Convalescent Plasma Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Browse Through More Reports Similar to the Global Convalescent Plasma Therapy Market 2026, By The Business Research Company

Blood Plasma Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Therapeutic Plasma Exchange Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Home Infusion Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795